![Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry | JCO Global Oncology Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry | JCO Global Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/go/2021/go.2021.7/go.20.00571/20210407/images/large/go.20.00571t2.jpeg)
Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry | JCO Global Oncology
![2020 Prostate Cancer Highlight - The Prostate Cancer Clinical Trials Consortium: Addressing Health Disparities by Increasing Diversity in Clinical Trials, Prostate Cancer Research Program, Congressionally Directed Medical Research Programs 2020 Prostate Cancer Highlight - The Prostate Cancer Clinical Trials Consortium: Addressing Health Disparities by Increasing Diversity in Clinical Trials, Prostate Cancer Research Program, Congressionally Directed Medical Research Programs](https://cdmrp.army.mil/images/misc/jake_vinson.jpg)
2020 Prostate Cancer Highlight - The Prostate Cancer Clinical Trials Consortium: Addressing Health Disparities by Increasing Diversity in Clinical Trials, Prostate Cancer Research Program, Congressionally Directed Medical Research Programs
![ASCO 2018: Enzalutamide Plus CC-115 in Men with mCRPC: A Phase 1b Prostate Cancer Clinical Trials Consortium Study ASCO 2018: Enzalutamide Plus CC-115 in Men with mCRPC: A Phase 1b Prostate Cancer Clinical Trials Consortium Study](https://www.urotoday.com/images/Rathkopf_Study_Schema.png)
ASCO 2018: Enzalutamide Plus CC-115 in Men with mCRPC: A Phase 1b Prostate Cancer Clinical Trials Consortium Study
![Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-01042-7/MediaObjects/41392_2022_1042_Fig1_HTML.png)
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
![A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study | Request PDF A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study | Request PDF](https://i1.rgstatic.net/publication/284185747_A_phase_II_trial_of_ganetespib_a_heat_shock_protein_90_Hsp90_inhibitor_in_patients_with_docetaxel-pretreated_metastatic_castrate-resistant_prostate_cancer_CRPC-a_prostate_cancer_clinical_trials_consor/links/5fbd27d9299bf104cf73b732/largepreview.png)
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study | Request PDF
![Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium | Karmanos News Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium | Karmanos News](https://www.karmanos.org/Uploads/Public/Images/Karmanos/News/heath-elizabeth.jpg)
Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium | Karmanos News
![Prostate Cancer Clinical Trial Consortium (PCCTC) and Sorrento Therapeutics, Inc : r/BANDOFBROTHERSOFSRNE Prostate Cancer Clinical Trial Consortium (PCCTC) and Sorrento Therapeutics, Inc : r/BANDOFBROTHERSOFSRNE](https://external-preview.redd.it/CVAu4L0jR8Ve14YD6MoqvSj2ec1RxKSn7TXHzw6Bqg0.jpg?width=640&crop=smart&auto=webp&s=5e6db1f8e63b031c68c2df1a3e13055affa93eef)